来源：美通社 上海2025年10月30日 /美通社/ -- 当新规持续收紧、AI重新定义工作边界、企业对财务的价值期待日益 攀升……多重压力下，今天的财务人，究竟该如何打破壁垒、形成合力？ Lucanet蓝科中国联合基因测序设备龙头华大智造、百年权威机构CIMA英国皇家特许管理会计师公会， 以及战略伙伴铂略举办"走进华大智造"研学活动，从技术、理论与实战三方视角，带来一场跨行业、多 视角的实地考察与深度对话。 01 实地探访：沉浸体验创新科技 活动伊始，与会嘉宾参观了华大时空中心展厅，近距离观摩华大智造在基因测序设备领域的前沿成就。 大湾区高端财经人士走进华大智造 华大智造作为全球化的基因测序设备制造商，其行业特性决定了财务管理需应对"高研发投入、强监管 合规、快技术迭代"三大挑战，这与当前多数行业面临的财务痛点高度契合，也使其实践具备了跨行业 借鉴价值。 02 主题分享：共享实践智慧 在主题分享环节，三位嘉宾聚焦不同维度，共同指向一个核心结论：当前财务数字化已超越用系统替代 手工的初级阶段，进入"能力重构"的深水区。 华大细胞营销副总裁赵鹏先生以《AI赋能基因细胞科技助力健康管理》为题，带来生命科学领域有趣 ...

重要内容提示： ? 本次股票上市类型为首发限售股份；股票认购方式为网下，上市股数为 本次股票上市流通总数为200,177,511股。 ? 本次股票上市流通日期为2025 年 9 月 9 日。 一、本次上市流通的限售股类型 经中国证券监督管理委员会《关于同意深圳华大智造科技股份有限公司首次 公开发行股票注册的批复》 （证监许可〔2022〕1638 号）同意，公司向社会公开发 证券代码：688114 证券简称：华大智造 公告编号：2025-056 深圳华大智造科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 行人民币普通股（A 股）41,319,475 股，并于 2022 年 9 月 9 日在上海证券交易所 科创板挂牌上市。公司首次公开发行 A 股前总股本为 371,790,525 股，首次公开发 行 A 股后总股本为 413,110,000 股，其中有限售条件流通股 381,217,890 股，无限 售条件流通股 31,892,110 股。具体情况详见公司于 2022 年 9 月 8 日在上海证券交 易所网站 ...

Board Meeting Overview - The second session of the company's second board meeting was held on August 21, 2025, with all 10 directors present, and the meeting was conducted in accordance with relevant laws and regulations [1] Financial Reports - The board approved the company's 2025 semi-annual report, confirming that it accurately reflects the company's financial status and operational conditions without any misleading statements or omissions [1][2] - The board also approved the special report on the storage and use of raised funds for the first half of 2025, stating compliance with regulations and proper management of the funds [2] Performance Evaluation - The board reviewed and approved the semi-annual evaluation report of the 2025 quality improvement and efficiency enhancement action plan, confirming its alignment with the company's objectives [3] Stock Incentive Plans - The board approved the revised draft of the 2024 restricted stock incentive plan, which includes new performance assessment indicators to ensure the effectiveness of the incentive program [4][5] - The board also approved the revised management measures for the 2024 restricted stock incentive plan, ensuring smooth implementation [6][7] Employee Stock Ownership Plans - The board approved the revised draft of the 2024 employee stock ownership plan, which includes new performance assessment indicators to enhance the plan's effectiveness [6][7] - The board also approved the revised management measures for the 2024 employee stock ownership plan, ensuring proper execution [7] Upcoming Shareholder Meeting - The company will hold its third extraordinary general meeting of shareholders on September 8, 2025, at the specified location [8]